quetiapin "actavis" 200 mg depottabletter
actavis group ptc ehf. - quetiapin fumarat - depottabletter - 200 mg
quetiapin "actavis" 300 mg depottabletter
actavis group ptc ehf. - quetiapin fumarat - depottabletter - 300 mg
quetiapin "actavis" 400 mg depottabletter
actavis group ptc ehf. - quetiapin fumarat - depottabletter - 400 mg
quetiapin "actavis" 50 mg depottabletter
actavis group ptc ehf. - quetiapin fumarat - depottabletter - 50 mg
abrysvo
pfizer europe ma eeig - respiratory syncytial virus, subgroup a, stabilized prefusion f protein / respiratory syncytial virus, subgroup b, stabilized prefusion f protein - respiratoriske syncytiale virusinfektioner - vacciner - abrysvo is indicated for:passive protection against lower respiratory tract disease caused by respiratory syncytial virus (rsv) in infants from birth through 6 months of age following maternal immunisation during pregnancy. se afsnit 4. 2 og 5. active immunisation of individuals 60 years of age and older for the prevention of lower respiratory tract disease caused by rsv. brug af denne vaccine bør være i overensstemmelse med de officielle anbefalinger.
centium 36 cs kapselsuspension
fmc europe nv, agrochemical products group - clomazon - kapselsuspension - 360 g/l clomazon
novitron dam tec vanddispergerbart granulat
fmc europe nv, agrochemical products group - aclonifen, clomazon - vanddispergerbart granulat - 500 g/kg aclonifen ; 30 g/kg clomazon
rinoter 50 mikrogram/dosis næsespray, suspension
farma group srl - mometasonfuroat monohydrat - næsespray, suspension - 50 mikrogram/dosis
actamone 10 mg filmovertrukne tabletter
rivopharm limited - montelukastnatrium - filmovertrukne tabletter - 10 mg
actamone 4 mg tyggetabletter
rivopharm limited - montelukastnatrium - tyggetabletter - 4 mg